We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$60.8B
1-Year Est. Return
42.06%
This Fund
S&P 500
This Quarter
Est. Return
+9.93%
1 Year Est. Return
+42.06%
3 Year Est. Return
+131.09%
5 Year Est. Return
+176.11%
10 Year Est. Return
–
AUM
$49.3B
AUM Growth
+$3.1B
(+6.7%)
Cap. Flow
-$516M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
27.74%
Holding
1,796
New
24
Increased
581
Reduced
361
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$78.5M |
| 2 |
NVIDIA
NVDA
|
+$75.6M |
| 3 |
Eli Lilly
LLY
|
+$70.2M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$58.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$55.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$107M |
| 2 |
Pfizer
PFE
|
+$70M |
| 3 |
Johnson & Johnson
JNJ
|
+$68M |
| 4 |
Danaher
DHR
|
+$56.4M |
| 5 |
Walmart Inc
WMT
|
+$54.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.47% |
| 2 | Healthcare | 17.5% |
| 3 | Financials | 11.6% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Xenon Pharmaceuticals
XENE
$5.79B
| $6.33M | 0.01% |
164,380
| – | – |
|
527
Raymond James Financial
RJF
$34.3B
| $6.32M | 0.01% |
60,940
+600
| +1% | +$55.7K |
|
528
JB Hunt Transport Services
JBHT
$25.7B
| $6.3M | 0.01% |
34,786
+7,085
| +26% | +$1.23M |
|
529
Allegion
ALLE
$13.4B
| $6.28M | 0.01% |
52,294
+25,050
| +92% | +$2.73M |
|
530
Replimune Group
REPL
$1.42B
| $6.27M | 0.01% |
270,007
| – | – |
|
531
AGNC Investment
AGNC
$12.6B
| $6.17M | 0.01% |
608,658
-2,739,060
| -82% | -$26.6M |
|
532
Ventas
VTR
$46.3B
| $6.14M | 0.01% |
129,879
+6,700
| +5% | +$304K |
|
533
Alliant Energy
LNT
$17.6B
| $6.14M | 0.01% |
116,984
| – | – |
|
534
BILL Holdings
BILL
$4.19B
| $6.13M | 0.01% |
52,432
-100
| -0.2% | -$9.5K |
|
535
GoDaddy
GDDY
$12.8B
| $6.12M | 0.01% |
81,485
-28,775
| -26% | -$2.12M |
|
|
IPG
536
DELISTED
Interpublic Group of Companies
IPG
| $6.08M | 0.01% |
157,543
+18,910
| +14% | +$713K |
|
537
Chipotle Mexican Grill
CMG
$46.8B
| $6.05M | 0.01% |
141,500
+48,000
| +51% | +$1.9M |
|
538
Ascendis Pharma A/S
ASND
$17.7B
| $6.04M | 0.01% |
67,693
| – | – |
|
539
Skyworks Solutions
SWKS
$11.1B
| $6.01M | 0.01% |
54,329
-5,510
| -9% | -$581K |
|
540
Ally Financial
ALLY
$13.3B
| $5.97M | 0.01% |
221,070
-92,945
| -30% | -$2.47M |
|
541
Booz Allen Hamilton
BAH
$8.76B
| $5.9M | 0.01% |
52,910
+6,015
| +13% | +$595K |
|
542
Outset Medical
OM
$67.5M
| $5.87M | 0.01% |
17,894
+1,116
| +7% | +$340K |
|
543
Corpay
CPAY
$27.3B
| $5.85M | 0.01% |
23,303
-1,080
| -4% | -$246K |
|
544
Mirum Pharmaceuticals
MIRM
$6.15B
| $5.84M | 0.01% |
225,700
| – | – |
|
545
Zebra Technologies
ZBRA
$17.2B
| $5.81M | 0.01% |
19,624
+300
| +2% | +$84.2K |
|
546
Bath & Body Works
BBWI
$3.93B
| $5.77M | 0.01% |
153,880
+33,240
| +28% | +$1.22M |
|
547
Williams-Sonoma
WSM
$26.8B
| $5.75M | 0.01% |
91,958
-37,060
| -29% | -$2.21M |
|
548
Dyne Therapeutics
DYN
$4.53B
| $5.75M | 0.01% |
511,293
+284,667
| +126% | +$3.36M |
|
549
Dropbox
DBX
$7.57B
| $5.71M | 0.01% |
214,135
-158,420
| -43% | -$3.61M |
|
550
Factset
FDS
$10.7B
| $5.71M | 0.01% |
14,253
+2,620
| +23% | +$1.06M |
|
Similar funds
Ensign Peak Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Ensign Peak Advisors held 1,796 positions worth $49.3B, up 6.7% from $46.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 3.3%. Ensign Peak Advisors opened 24 new positions and exited 35, leaving the 1,796-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q2 2023 buy was First Horizon: 875,834 shares worth $9.87M.
- Ensign Peak Advisors added most to Microsoft in Q2 2023, an estimated $78.5M increase.
- Ensign Peak Advisors's biggest Q2 2023 reduction was AbbVie, cutting an estimated $107M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $45M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $49.3B portfolio in Q2 2023.
- Ensign Peak Advisors opened 24 new positions and closed 35 in Q2 2023.
- Ensign Peak Advisors's portfolio value rose 6.7% quarter-over-quarter to $49.3B.
Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.